Durgical
EN
Open the app

Wake-promoting agents and narcolepsy drugs

Non-amphetamine medicines that reduce excessive daytime sleepiness in narcolepsy, sleep apnoea or shift work; sodium oxybate also treats cataplexy.

Updated

What they are

A group of drugs for excessive daytime sleepiness. Modafinil and armodafinil block dopamine reuptake; solriamfetol blocks noradrenaline reuptake; pitolisant blocks histamine H3 receptors; sodium oxybate (GHB) is taken at night and acts through GABA-B receptors. None cures the sleep disorder; in sleep apnoea they treat the sleepiness, not the airway.

Mechanism of action

Each drug raises the activity of a wake-promoting signal: dopamine (modafinil, armodafinil), noradrenaline (solriamfetol) or histamine released when the H3 brake is blocked (pitolisant). Sodium oxybate works differently: it is taken at night and is thought to act through GABA-B receptors; it reduces daytime sleepiness and cataplexy.

Target: Dopamine transporter (DAT); noradrenaline transporter (NET); histamine H3 receptor; GABA-B receptor

Drugs in this class

Others in the class

  • Methylphenidate and amphetamines (stimulants; see ADHD agents)

Test yourself

Think of the answer, then tap the question to see it.

Which wake-promoting drug is taken at night, in bed?

Sodium oxybate, which reduces cataplexy and daytime sleepiness.

How does pitolisant increase wakefulness?

It blocks the histamine H3 receptor, a brake on histamine release, so wake-promoting histamine rises.

What must happen if a rash appears on modafinil?

The drug is stopped unless the rash is clearly unrelated, because of the risk of SJS and DRESS.

Add to my cards (3)

More Pharmacology questions →

← All of pharmacology

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - MODAFINIL tablet (DailyMed (U.S. National Library of Medicine), 2026); DailyMed - SODIUM OXYBATE solution (DailyMed (U.S. National Library of Medicine), 2026); Pitolisant: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.